Taubman Scholar

UM Startup In California Raises $82M In IPOOncoMed Pharmaceuticals, a California-based company started at the University of Michigan in 2004 with Taubman Scholar Max Wicha, M.D., as co-founder, raised $82 million in an initial public offering that ended last week.
Taubman Institute Appoints New Scholar, Emerging ScholarTwo University of Michigan clinician-scientists will receive three-year grants to pursue translational medical research aimed at helping patients with life-altering neurological disorders, the A. Alfred Taubman Medical Research Institute announced.